Responses
Regular and young investigator award abstracts
Combination immunotherapies
467 Anti-EGFR antibody added to ongoing anti-PD-1 antibody treatment for metastatic cutaneous squamous cell carcinoma of the face: two case reports
Compose a Response to This Article
Other responses
No responses have been published for this article.
